P-glycoprotein, secretory transport, and other barriers to the oral delivery of anti-HIV drugs
- 20 September 1999
- journal article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 39 (1-3), 105-116
- https://doi.org/10.1016/s0169-409x(99)00022-8
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- SaquinavirClinical Pharmacokinetics, 1998
- Clinical Pharmacokinetics of StavudineClinical Pharmacokinetics, 1997
- Human immunodeficiency virus protease inhibitors From drug design to clinical studiesAdvanced Drug Delivery Reviews, 1997
- Drug Interactions with Antiviral DrugsClinical Pharmacokinetics, 1996
- ZalcitabineClinical Pharmacokinetics, 1995
- Biopharmaceutics of Didanosine in Humans and in a Model for Acid-Labile Drugs, the Pentagastrin-Pretreated DogPharmaceutical Research, 1993
- Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome—related complexClinical Pharmacology & Therapeutics, 1991
- Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cellsBiochemical and Biophysical Research Communications, 1991
- Characterization of the Human Colon Carcinoma Cell Line (Caco-2) as a Model System for Intestinal Epithelial PermeabilityGastroenterology, 1989
- Preformulation solubility and kinetic studies of 2',3'-dideoxypurine nucleosides: potential anti-AIDS agentsInternational Journal of Pharmaceutics, 1988